Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2003
10/02/2003WO2003080592A1 2-pyrone compounds and use thereof
10/02/2003WO2003080586A1 N-sulfonylurea apoptosis promoters
10/02/2003WO2003080579A1 Novel adamantane derivatives
10/02/2003WO2003080578A1 Heteroaromatic urea derivatives as vr-1 receptor modulators for treating pain
10/02/2003WO2003080574A1 Piperidine or 8-aza-bicyclo[3.2.1]oct-3-yl derivatives useful as modulators of chemokine receptor activity (especially ccr5)
10/02/2003WO2003080568A2 Probucol derivatives
10/02/2003WO2003080566A2 Hif hydroxylase inhibitors
10/02/2003WO2003080184A1 1,2-dihydropyrazol-3-ones as cytokine mediators
10/02/2003WO2003080183A1 Pharmaceutical combination of the cox-2 inhibitor etodolac and opioids
10/02/2003WO2003080125A2 Benzimidazoles and their use as mitogen-activated- and rho-kinase inhibitors
10/02/2003WO2003080118A2 Combination of an aldosterone receptor antagonist and a fibric acid derivative
10/02/2003WO2003080105A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003WO2003080084A1 A process for the extraction of anthocyanins from black rice and composition thereof
10/02/2003WO2003080071A1 Novel therapeutical use of agonist ligands specific to g2a receptor
10/02/2003WO2003080069A1 Combination of an aldosterone receptor antagonist and a bile acid sequestering agent
10/02/2003WO2003080064A1 Kinase inhibitors
10/02/2003WO2003080058A1 Benzylimidazolyl substituted 2-quinoline and quinazoline derivatives for use as farnesyl transferase inhibitors
10/02/2003WO2003080054A1 Use of pyridyl amides as inhibitors of angiogenesis
10/02/2003WO2003080053A1 Combination treatments for chemokine-mediated diseases
10/02/2003WO2003080049A1 (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof
10/02/2003WO2003080044A1 Anti-cancer combinations of dmxaa and a nsaid
10/02/2003WO2003080042A1 Decomposition inhibitor for extracellular matrix of cartilage
10/02/2003WO2003080041A1 Remedies for arthritis deformans
10/02/2003WO2003080040A1 Diclofenac sodium oral pharmaceutical
10/02/2003WO2003080029A1 No-donating nsaids adsorbed into carrier particles
10/02/2003WO2003080024A2 Nanoparticulate compositions of map kinase inhibitors
10/02/2003WO2003080022A2 Analgesics for nasal administration
10/02/2003WO2003080021A2 Formulation comprising buprenorphine
10/02/2003WO2003079969A2 Compositions and methods for treating and preventing necrosis
10/02/2003WO2003079750A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
10/02/2003WO2003064441A3 Oligonucleotides comprising alternating segments and uses thereof
10/02/2003WO2003063898A3 Method of treating pain with botulinum toxin
10/02/2003WO2003062414A3 Methods of obtaining isoform specific expression in mammalian cells
10/02/2003WO2003049725A3 Compositions for the treatment of lupus, other rheumatic diseases and joint diseases
10/02/2003WO2003042173A8 Nk1 antagonists
10/02/2003WO2003028692A3 Acne treatment using oleanolic acid
10/02/2003WO2003009779A3 Delivery of therapeutic capable agents
10/02/2003WO2002092759A3 Molecules for disease detection and treatment
10/02/2003WO2002074323A3 Using neural thread proteins to treat tumors and other hyperproliferative disorders
10/02/2003WO2002069944A3 Novel medicament compositions based on anticholinergics and on nk1 receptor antagonists
10/02/2003WO2002030940A3 Low molecular serine protease inhibitors comprising polyhydroxy-alkyl and polyhydroxy-cycloalkyl radicals
10/02/2003WO2002030870A3 Substituted c-cyclohexylmethylamine derivatives
10/02/2003WO2002026781A3 Ige receptor antagonists
10/02/2003WO2002022573A3 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
10/02/2003WO2002018404A9 Nucleoside derivatives for the treatment of hepatitis c
10/02/2003WO2002005782A3 Stable salts of o-acetylsalicyclic with basic amino acids
10/02/2003WO2002000656A3 Pirazino '1$m(1)2$m(1) :1, 6! pyrido '3,4-b! indole derivatives
10/02/2003WO2001098508A3 Transgenic mice containing targeted gene disruptions
10/02/2003US20030187302 Enzyme inhibitors, 1-(4-methanesulfonyl-benzylidene)-3,4-dihydro-1H-naphthalene-2 -one oxime
10/02/2003US20030187289 A biphenyl-alkyloxy-benzoylamino-propionic acid or amide derivatives; treating thrombosis, cardiovascular disorders, arteriosclerosis, inflammation, tumor, osteoporosis, angioplasty aftertreatment
10/02/2003US20030187276 Hydrophobic polyamine analogs and methods for their use
10/02/2003US20030187261 Purine derivatives, process for their preparation and use thereof
10/02/2003US20030187257 Phosphodiesterase inhibitor; antiinflammatory agnets, autoimmune disease; antihistamine agents; skin disorders
10/02/2003US20030187245 Comprises expression vectors coding proteins for regulation and expression of transgenes and treatment of allergies, inflammation, arthritis and nervous system disorders; gene therapy; antiproliferative agents
10/02/2003US20030187224 Chimeric OPG polypeptides
10/02/2003US20030187052 Controrlling concentration of tumor necrosis factor, phosphodiesterase inhibitor; controlling cell differentiation, proliferation; antiinflammatory agents; cardiovascular disorders
10/02/2003US20030187050 Crystal structure; stability; bioavailability
10/02/2003US20030187037 Cardiovascular disorders; antiinflammatory agents; antitumor agents
10/02/2003US20030187035 Substituted hydrazones as inhibitors of cyclooxygenase-2
10/02/2003US20030187034 Composition containing at least one aryl oxime and at least one active substance for treating acne and the use thereof
10/02/2003US20030187031 Antiinflammatory agents; autoimmune disease; rheumatic disorders
10/02/2003US20030187024 Vision disorders; antiinflammatory agents; autoimmune disease; anticancer qgents; skin disorders
10/02/2003US20030187020 Chemical compounds
10/02/2003US20030187014 Condensed pyrazole derivatives, process for producing the same and use thereof
10/02/2003US20030187012 Reduction physical cigarette smoking
10/02/2003US20030187009 Analgesics, diarrhea, anticonvulsants, antitussive agents or drug abuse therapy
10/02/2003US20030187007 Inhibitors of protein kinase for the treatment of disease
10/02/2003US20030186996 Angiogenesis inhibitors
10/02/2003US20030186989 Antihistamines; respiratory system disorders
10/02/2003US20030186988 Lymphocyte disease; autoimmune disease
10/02/2003US20030186987 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
10/02/2003US20030186985 Oxyiminoalkanoic acid derivatives
10/02/2003US20030186981 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases
10/02/2003US20030186974 Pyrrolyl- and imidazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
10/02/2003US20030186966 Antiinflammatory agents; autoimmune disease; antiallergens
10/02/2003US20030186964 Piperdines for use as orexin receptor antagonists
10/02/2003US20030186958 Viricides, vision defects, oral diseases, antiarthritic agents, multiple sclerosis, anticancer agents
10/02/2003US20030186951 Compositions and methods for enhancing corticosteroid delivery
10/02/2003US20030186943 Substituted gamma-phenyl-delta-lactams and uses related thereto
10/02/2003US20030186941 Cyclopenteneone derivatives
10/02/2003US20030186934 For use as skin-whitening agents; side effects reduction
10/02/2003US20030186926 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof
10/02/2003US20030186922 Therapeutic use of cis-element decoys in vivo
10/02/2003US20030186897 Derivatives of branched-chain lipophilic molecules and uses thereof
10/02/2003US20030186894 Dry powder compositions having improved dispersivity
10/02/2003US20030186889 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction
10/02/2003US20030186880 Combination therapy using trefoil peptides
10/02/2003US20030186875 Uses of mammalian cytokine; related reagents
10/02/2003US20030186842 Contacting a cell population with an inhibiting effective amount of a reagent that suppresses the protease activity of at least one member of the interleukin-1beta- converting enzyme (ICE)/CED-3 family
10/02/2003US20030186391 Viral material and nucleotide fragments associated with multiple sclerosis, for diagnostic, prophylactic and therapeutic purpose
10/02/2003US20030186325 Method of screening for inhibitors of osteopontin
10/02/2003US20030186308 Prostacyclin-stimulating factor-2
10/02/2003US20030185918 First ingredient obtainable from turmeric; a second ingredient obtainable from ginger; and a third ingredient obtainable from horseradish; treating viral infections
10/02/2003US20030185912 Anti-microbial compositions and methods of using same
10/02/2003US20030185890 Compositions and methods for polynucleotide delivery
10/02/2003US20030185869 Having lysozyme adsorbed onto or associated with the surface of an active agent
10/02/2003US20030185824 Administering an inhibitor of the CD2/LFA-3 interaction, in combination with an auxiliary agent, such as UV-B
10/02/2003US20030185819 Treatment of specific and non-specific inflammation, including asthma; useful in diagnosing and localizing sites of inflammation.
10/02/2003US20030185818 Humanized antibody against cd18
10/02/2003US20030185816 Modified immunogenic self-protein and a surfactant capable of acting as a solubiliser, especially modified human TNF alpha and cetylpyridinium chloride
1 ... 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 ... 1272